Bone Density Reduction: Tenofovir has long been associated with a decrease in bone mineral density, raising the potential risk of bone difficulties or fractures.Administration of large doses of tenofovir has become described to provide bone toxicity described as osteomalacia and reduced bone mineral density and to create some degree of renal toxici